SIREN : 899401848
LAZEO MEDICAL NANTES is a French company founded 4 years ago, specialized in the sector Soins de beauté. Based in NANTES (44000), this company of category ETI shows in 2023 a revenue of 930 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 |
|---|---|
| Revenue | 930 446 € |
| Net income | 100 253 € |
| EBITDA | 132 698 € |
| Net margin | 10.8% |
In 2023, LAZEO MEDICAL NANTES achieves revenue of 930 k€. After deducting consumption (18 k€), gross margin stands at 912 k€, i.e. a rate of 98%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 133 k€, representing 14.3% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 100 k€, i.e. 10.8% of revenue. This profit can be retained or distributed to shareholders.
930 446 €
912 327 €
132 698 €
82 016 €
100 253 €
14.3%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Cash flow represents 16.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.0%
49.387%
16.222%
0.0
63.4%
In 2023, the debt ratio of LAZEO MEDICAL NANTES (0.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2023, the financial autonomy of LAZEO MEDICAL NANTES (49.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2023, the repayment capacity of LAZEO MEDICAL NANTES (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 271.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
271.456
0.0
In 2023, the liquidity ratio of LAZEO MEDICAL NANTES (271.46) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2023, the interest coverage of LAZEO MEDICAL NANTES (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 32 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 254 days. Excellent situation: suppliers finance 222 days of the operating cycle (retail model). Inventory turnover is 2 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 381 days of revenue, i.e. 984 k€ to permanently finance.
984 077 €
32 j
254 j
2 j
381 j
Based on 84 transactions of similar company sales
in 2023,
the value of LAZEO MEDICAL NANTES is estimated at
589 671 €
(range 298 832€ - 979 657€).
With an EBITDA of 132 698€, the sector multiple of 5.2x is applied.
The price/revenue ratio is 0.53x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 84 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare LAZEO MEDICAL NANTES with other companies in the same sector:
The revenue of LAZEO MEDICAL NANTES in 2023 is 930 k€.
Yes, LAZEO MEDICAL NANTES generated a net profit of 100 k€ in 2023.
The headquarters of LAZEO MEDICAL NANTES is located in NANTES (44000), in the department Loire-Atlantique.
The tax return of LAZEO MEDICAL NANTES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
LAZEO MEDICAL NANTES operates in the sector Soins de beauté (NAF code 96.02B). See the 'Sector positioning' section above to compare the company with its competitors.